Page last updated: 2024-09-05

sb 216763 and Cryptogenic Fibrosing Alveolitis

sb 216763 has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agostini, C; Biasutto, L; Brunetta, E; Cabrelle, A; Calabrese, F; Cinetto, F; Facco, M; Garbisa, S; Gattazzo, C; Gnoato, M; Gurrieri, C; Montini, B; Niero, R; Piazza, F; Semenzato, G	1

Other Studies

1 other study(ies) available for sb 216763 and Cryptogenic Fibrosing Alveolitis

Article	Year
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:3 Topics: Animals; Bleomycin; Chemokine CCL2; Glycogen Synthase Kinase 3; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Macrophages; Maleimides; Mice; Mice, Inbred C57BL; Pneumonia; Pulmonary Alveoli; Respiratory Mucosa; Tumor Necrosis Factor-alpha	2010

Article

Year

3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.

The Journal of pharmacology and experimental therapeutics, 2010, Volume: 332, Issue:3

Topics: Animals; Bleomycin; Chemokine CCL2; Glycogen Synthase Kinase 3; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Macrophages; Maleimides; Mice; Mice, Inbred C57BL; Pneumonia; Pulmonary Alveoli; Respiratory Mucosa; Tumor Necrosis Factor-alpha

2010